{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:15:44Z","timestamp":1793312144924,"version":"4.5.0"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC) exhibits a profoundly immunosuppressive tumor microenvironment, with tumor-associated macrophages (TAMs) being the most abundant immune infiltrate. Among them, lipid-associated macrophages (LAMs) have emerged as a distinct subpopulation driving immune evasion through metabolic reprogramming.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a narrative review by systematically searching PubMed, Web of Science, and Scopus for articles on LAMs in PDAC up to December 2023. Key themes were synthesized to cover defining markers, metabolic pathways, immunosuppressive functions, and therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>LAMs are characterized by co-expression of TREM2, APOE, CD9, and lipid-handling genes, and their accumulation correlates with poor prognosis. They undergo metabolic rewiring involving CD36-mediated lipid uptake, dysregulated cholesterol efflux, fatty acid oxidation, and de novo lipogenesis, which collectively enforce an immunosuppressive phenotype. LAMs interact bidirectionally with cancer-associated fibroblasts and directly suppress CD8+ T cells and NK cells. Preclinical targeting of CD36, TREM2, or FAO shows promise but faces challenges in toxicity and delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>LAMs represent a potential therapeutic vulnerability in PDAC, but the field is still in its early stages. Future work should focus on establishing causal evidence in PDAC-specific models, developing tumor-selective delivery systems, and validating biomarkers for patient stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1865859","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:55:14Z","timestamp":1782280514000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Metabolic regulation and immunosuppressive functions of lipid-associated macrophages in pancreatic ductal adenocarcinoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Tongyuan","family":"Zhang","sequence":"first","affiliation":[{"name":"Renmin Hospital of Wuhan University","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingze","family":"Zhang","sequence":"additional","affiliation":[{"name":"Renmin Hospital of Wuhan University","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"He","sequence":"additional","affiliation":[{"name":"General Administration Office, Renmin Hospital of Wuhan University","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hepatopancreatobiliary Surgery, Renmin Hospital of Wuhan University","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70043","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122642","article-title":"Newly emerging immune checkpoints: Promises for future cancer therapy","volume":"18","author":"Torphy","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-15-0255","article-title":"Classifying cancers based on T-cell infiltration and PD-L1","volume":"75","author":"Teng","year":"2015","journal-title":"Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: From mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.05.054","article-title":"Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner","volume":"178","author":"Jaitin","year":"2019","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer's disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.117.312509","article-title":"Single-cell RNA-seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis","volume":"122","author":"Cochain","year":"2018","journal-title":"Circ Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13887","article-title":"SPP1+ macrophages: A call for reclassification","volume":"174","author":"Zhang","year":"2025","journal-title":"Immunology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-20-3715","article-title":"Inhibition of Hedgehog signaling alters fibroblast composition in pancreatic cancer","volume":"27","author":"Steele","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.04.014","article-title":"CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma","volume":"29","author":"Steele","year":"2016","journal-title":"Cancer Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-019-0195-y","article-title":"Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma","volume":"29","author":"Peng","year":"2019","journal-title":"Cell Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00356-8","article-title":"TREM2 marks tumor-associated macrophages","volume":"5","author":"Nakamura","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00420","article-title":"Metabolic reprogramming in macrophage polarization","volume":"5","author":"Galvan-Pena","year":"2014","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-022-01017-3","article-title":"Lipid metabolism in T cell signaling and function","volume":"18","author":"Lim","year":"2022","journal-title":"Nat Chem Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-0912","article-title":"Targeting peroxisome proliferator-activated receptor gamma in tumor-associated macrophages","volume":"83","author":"Park","year":"2023","journal-title":"Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01149-7","article-title":"Targeting macrophage metabolism to enhance tumor immunotherapy","volume":"21","author":"Liu","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGFbeta in cancer","volume":"134","author":"Massague","year":"2008","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137345","article-title":"Pre-clinical development of a humanized anti-CD47 antibody with anti-cancer therapeutic potential","volume":"10","author":"Liu","year":"2015","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-024-01296-w","article-title":"Macrophage heterogeneity and its interactions with stromal cells in tumour microenvironment","volume":"14","author":"Chen","year":"2024","journal-title":"Cell Biosci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1121623109","article-title":"The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors","volume":"109","author":"Willingham","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2444","article-title":"The role of myeloid cells in the promotion of tumour angiogenesis","volume":"8","author":"Murdoch","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01445-3","article-title":"Macrophage barrier in the tumor microenvironment and potential clinical applications","volume":"22","author":"Wang","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2003782","article-title":"Identifying off-target effects of etomoxir reveals that carnitine palmitoyltransferase I is essential for cancer cell proliferation independent of beta-oxidation","volume":"16","author":"Yao","year":"2018","journal-title":"PloS Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2956","article-title":"Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages","volume":"15","author":"Huang","year":"2014","journal-title":"Nat Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Costa-Silva","year":"2015","journal-title":"Nat Cell Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.02.001","article-title":"Macrophage-released pyrimidines inhibit gemcitabine therapy in pancreatic cancer","volume":"29","author":"Halbrook","year":"2019","journal-title":"Cell Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3109\/08820139.2012.680634","article-title":"Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives","volume":"41","author":"Raber","year":"2012","journal-title":"Immunol Invest"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2681","article-title":"Sterols and oxysterols in immune cell function","volume":"14","author":"Spann","year":"2013","journal-title":"Nat Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1376348","article-title":"Metabolic reprogramming of tumor-associated macrophages: the intersection of lipids, mitochondria, and immunity","volume":"15","author":"Zhou","year":"2024","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02020-5","article-title":"The emerging role of TREM2 in tumor immunotherapy: mechanisms and clinical implications","volume":"23","author":"Huang","year":"2024","journal-title":"Mol Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0880-x","article-title":"BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial","volume":"26","author":"Bockorny","year":"2020","journal-title":"Nat Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.116943","article-title":"Targeting fatty acid synthase for cancer drug discovery","volume":"280","author":"Liu","year":"2025","journal-title":"Eur J Med Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2024.10.007","article-title":"Lactate: a rising star in tumors and inflammation","volume":"45","author":"Zhang","year":"2024","journal-title":"Trends Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.06.032","article-title":"Coupled scRNA-seq and intracellular protein activity reveal an immunosuppressive role of TREM2 in cancer","volume":"182","author":"Katzenelenbogen","year":"2020","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S456789","article-title":"Single-cell RNA sequencing identifies crucial genes in hepatocellular carcinoma tumor-associated macrophages","volume":"11","author":"Li","year":"2024","journal-title":"J Hepatocell Carcinoma"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-20-3929","article-title":"Apolipoprotein E promotes immune suppression in pancreatic cancer through NF-\u03baB-mediated production of CXCL1","volume":"81","author":"Kemp","year":"2021","journal-title":"Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190673","article-title":"Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis","volume":"217","author":"Lin","year":"2020","journal-title":"J Exp Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/s1471-4906(02)02302-5","article-title":"Macrophage polarization: Tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: Nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0392-8","article-title":"Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas","volume":"38","author":"Moncada","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05361-3","article-title":"Progress of single-cell RNA sequencing combined with spatial transcriptomics in tumour microenvironment and treatment of pancreatic cancer","volume":"22","author":"Wang","year":"2024","journal-title":"J Transl Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01890-9","article-title":"Spatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment","volume":"56","author":"Shiau","year":"2024","journal-title":"Nat Genet"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1126\/science.1178331","article-title":"Development of monocytes, macrophages, and dendritic cells","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.07.014","article-title":"Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression","volume":"47","author":"Zhu","year":"2017","journal-title":"Immunity"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-313738","article-title":"Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma","volume":"67","author":"Nywening","year":"2018","journal-title":"Gut"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-13-0525","article-title":"Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: A role for targeting the CCL2\/CCR2 axis","volume":"19","author":"Sanford","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in \u03b1SMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405746121","article-title":"Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2","volume":"121","author":"Ganguly","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Cancer Cell"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-19-1999","article-title":"Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance","volume":"80","author":"Mukherjee","year":"2020","journal-title":"Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.09.002","article-title":"Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming","volume":"33","author":"Morrissey","year":"2021","journal-title":"Cell Metab"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2023.0182","article-title":"Lipid metabolic regulatory crosstalk between cancer cells and tumor-associated macrophages","volume":"20","author":"Wang","year":"2023","journal-title":"Cancer Biol Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01134-8","article-title":"Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment","volume":"54","author":"Hwang","year":"2022","journal-title":"Nat Genet"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2025.02.017","article-title":"TREM2 depletion in pancreatic cancer elicits pathogenic inflammation and macrophage accumulation","volume":"168","author":"Yang","year":"2025","journal-title":"Gastroenterology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-15-2613","article-title":"The role of cholesterol in cancer","volume":"76","author":"Kuzu","year":"2016","journal-title":"Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2023.01.005","article-title":"TREM2: A new player in the tumor microenvironment","volume":"9","author":"Molgora","year":"2023","journal-title":"Trends Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2014.38","article-title":"CD36, a scavenger receptor implicated in atherosclerosis","volume":"46","author":"Park","year":"2014","journal-title":"Exp Mol Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.10.006","article-title":"The fatty acid receptor CD36 promotes macrophage infiltration via p110\u03b3 signaling to stimulate metastasis","volume":"63","author":"Chen","year":"2024","journal-title":"J Adv Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2006.05.011","article-title":"Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation","volume":"4","author":"Vats","year":"2006","journal-title":"Cell Metab"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202002054","article-title":"Engineering macrophages for cancer immunotherapy and drug delivery","volume":"32","author":"Xia","year":"2020","journal-title":"Adv Mater"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/stem.1716","article-title":"Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression","volume":"32","author":"Hale","year":"2014","journal-title":"Stem Cells"},{"key":"B70","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Vegelia","year":"2018","journal-title":"Nat Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.08.003","article-title":"iNKT cells induce FGF21 for thermogenesis and are required for maximal weight loss in GLP1 therapy","volume":"24","author":"Lynch","year":"2016","journal-title":"Cell Metab"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.991790","article-title":"Tumor apolipoprotein E is a key checkpoint blocking anti-tumor immunity in mouse melanoma","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00440-5","article-title":"SREBP1-induced fatty acid synthesis depletes macrophages antioxidant defences to promote their alternative activation","volume":"3","author":"Bidault","year":"2021","journal-title":"Nat Metab"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-18-0710","article-title":"IL1-induced JAK\/STAT signaling is antagonized by TGFbeta to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov"},{"key":"B75","doi-asserted-by":"crossref","DOI":"10.1038\/ncb3094","article-title":"Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis","volume":"17","author":"Fong","year":"2015","journal-title":"Nat Cell Biol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1256890","article-title":"Targeting reactive oxygen species and fatty acid oxidation in tumor-associated macrophages","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-07-0912","article-title":"Tumor-associated macrophages press the angiogenic switch in breast cancer","volume":"67","author":"Lin","year":"2007","journal-title":"Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-11-3114","article-title":"The pancreas cancer microenvironment","volume":"18","author":"Feig","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.08.015","article-title":"Interleukin-34-orchestrated tumor-associated macrophage reprogramming is required for tumor immune escape driven by p53 inactivation","volume":"57","author":"Nian","year":"2024","journal-title":"Immunity"},{"key":"B84","article-title":"Metabolism of tumor-associated macrophages: a new dimension in cancer immunotherapy","volume":"30","author":"Xu","year":"2024","journal-title":"Trends Mol Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B86","article-title":"Lipid-laden macrophages in cancer: metabolism, function, and therapeutic potential","volume":"10","author":"Wu","year":"2024","journal-title":"Trends Cancer"},{"key":"B87","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-065X.2008.00608.x","article-title":"Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives","volume":"222","author":"Rodriguez","year":"2008","journal-title":"Immunol Rev"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-68109-z","article-title":"CTHRC1+ fibroblasts and SPP1+ macrophages synergistically contribute to pro-tumorigenic tumor microenvironment in pancreatic ductal adenocarcinoma","volume":"14","author":"93Li","year":"2024","journal-title":"Sci Rep"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2022.04.008","article-title":"Macrophage diversity in cancer revisited in the era of single-cell omics","volume":"43","author":"Ma","year":"2022","journal-title":"Trends Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-015-0094-9","article-title":"Targeting the indoleamine 2,3-dioxygenase pathway in cancer","volume":"3","author":"Moon","year":"2015","journal-title":"J Immunother Cancer"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(16)00078-4","article-title":"Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial","volume":"17","author":"Nywening","year":"2016","journal-title":"Lancet Oncol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.05.016","article-title":"Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy","volume":"25","author":"Ries","year":"2014","journal-title":"Cancer Cell"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0804-9","article-title":"Phase I study of RG7155, a novel anti-CSF1R antibody, in patients with advanced\/metastatic solid tumors","volume":"7","author":"Gomez-Roca","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114198","article-title":"Macrophage-based cancer immunotherapy: challenges and opportunities","volume":"434","author":"Bai","year":"2024","journal-title":"Exp Cell Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216221","article-title":"Cholesterol efflux in tumor-associated macrophages: a novel immunotherapeutic target","volume":"562","author":"Chen","year":"2023","journal-title":"Cancer Lett"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109844","article-title":"Targeting TREM2 on tumor-associated macrophages enhances immunotherapy","volume":"37","author":"Molgora","year":"2021","journal-title":"Cell Rep"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-024-03764-5","article-title":"Lipid metabolism reprogramming of tumor-associated macrophages and their role in tumor progression","volume":"73","author":"Bian","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01127-z","article-title":"Emerging roles of lipid metabolism in tumor-associated macrophages","volume":"21","author":"Luo","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-024-00315-9","article-title":"The role of lipid metabolism in regulating immune cell function in cancer","volume":"12","author":"Tanaka","year":"2024","journal-title":"Cancer Metabol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-019-0570-3","article-title":"Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies","volume":"14","author":"Sung","year":"2019","journal-title":"Nat Nanotechnol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02047-8","article-title":"Single-cell signatures identify microenvironment factors that predict immunotherapy response in pancreatic cancer","volume":"23","author":"Wu","year":"2024","journal-title":"Mol Cancer"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00722-6","article-title":"Dissecting the tumor microenvironment with single-cell and spatial transcriptomics","volume":"24","author":"Kim","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15965","article-title":"Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism","volume":"8","author":"Biancur","year":"2017","journal-title":"Nat Commun"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211314","article-title":"CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate","volume":"219","author":"Huynh","year":"2022","journal-title":"J Exp Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual","year":"2017","journal-title":"Nature"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33349-y","article-title":"CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis","volume":"13","author":"Yang","year":"2022","journal-title":"Nat Commun"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3337","article-title":"CSF-1R inhibition alters macrophage polarization and blocks glioma progression","volume":"19","author":"Pyonteck","year":"2013","journal-title":"Nat Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr Biol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01089-8","article-title":"Lipid droplets in cancer: multifaceted roles and therapeutic targeting","volume":"20","author":"Guo","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1056892","article-title":"The role of FABP5 in macrophage lipid metabolism and inflammatory responses","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01702-2","article-title":"Targeting lipid metabolism for cancer therapy","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1865859\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:55:16Z","timestamp":1782280516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1865859\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":111,"alternative-id":["10.3389\/fimmu.2026.1865859"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1865859","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"article-number":"1865859"}}